Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.37B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.12B |
| 3 |
GE Aerospace
GE
|
+$499M |
| 4 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$344M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$645M |
| 2 |
Lockheed Martin
LMT
|
+$300M |
| 3 |
Xcel Energy
XEL
|
+$292M |
| 4 |
Apple
AAPL
|
+$284M |
| 5 |
Linde
LIN
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.32% |
| 2 | Financials | 8.18% |
| 3 | Healthcare | 6.01% |
| 4 | Industrials | 5.88% |
| 5 | Consumer Discretionary | 5.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
Stoneridge
SRI
$213M
| $100K | ﹤0.01% |
16,021
+3,490
| +28% | +$26.8K |
|
5027
Kaltura
KLTR
$267M
| $100K | ﹤0.01% |
45,550
+15,944
| +54% | +$29.1K |
|
|
CMRX
5028
DELISTED
Chimerix, Inc.
CMRX
| $100K | ﹤0.01% |
28,739
| – | – |
|
5029
Fidelity Enhanced International ETF
FENI
$11.2B
| $99.7K | ﹤0.01% |
3,623
+1,429
| +65% | +$40.9K |
|
5030
Lifecore Biomedical
LFCR
$190M
| $99.4K | ﹤0.01% |
13,381
+3,012
| +29% | +$19.2K |
|
5031
Smith-Midland
SMID
$152M
| $99.4K | ﹤0.01% |
2,235
+851
| +61% | +$33.8K |
|
5032
Pangaea Logistics
PANL
$485M
| $98.6K | ﹤0.01% |
18,396
+4,007
| +28% | +$24.1K |
|
5033
Citi Trends
CTRN
$605M
| $98.3K | ﹤0.01% |
3,745
+695
| +23% | +$14.6K |
|
5034
Escalade
ESCA
$311M
| $98.1K | ﹤0.01% |
6,870
+1,278
| +23% | +$18.5K |
|
5035
Concentrix
CNXC
$1.57B
| $97.9K | ﹤0.01% |
2,263
-537
| -19% | -$23.9K |
|
5036
Invesco Dorsey Wright Utilities Momentum ETF
PUI
$54.4M
| $97.7K | ﹤0.01% |
2,526
+86
| +4% | +$3.46K |
|
5037
Chegg
CHGG
$102M
| $97.4K | ﹤0.01% |
60,526
+4,243
| +8% | +$7.82K |
|
5038
Bel Fuse Inc Class A
BELFA
$3.37B
| $97.2K | ﹤0.01% |
1,079
+223
| +26% | +$22K |
|
|
LNKB
5039
DELISTED
LINKBANCORP
LNKB
| $97.2K | ﹤0.01% |
12,989
+2,829
| +28% | +$20.1K |
|
5040
Sutro Biopharma
STRO
$421M
| $97K | ﹤0.01% |
5,274
+1,047
| +25% | +$32K |
|
5041
MacroGenics
MGNX
$257M
| $97K | ﹤0.01% |
29,838
+9,312
| +45% | +$33.5K |
|
5042
iShares Convertible Bond ETF
ICVT
$7.35B
| $96.8K | ﹤0.01% |
1,139
+478
| +72% | +$41.1K |
|
5043
Rocky Brands
RCKY
$369M
| $96.6K | ﹤0.01% |
4,236
+1,007
| +31% | +$24.6K |
|
5044
iShares Investment Grade Systematic Bond ETF
IGEB
$1.46B
| $96.6K | ﹤0.01% |
2,177
+2,015
| +1,244% | +$91.1K |
|
5045
Blink Charging
BLNK
$87.9M
| $96.5K | ﹤0.01% |
69,436
+245
| +0.4% | +$433 |
|
|
MRSN
5046
DELISTED
Mersana Therapeutics
MRSN
| $96.5K | ﹤0.01% |
2,699
+774
| +40% | +$40K |
|
5047
Acacia Research
ACTG
$470M
| $96.2K | ﹤0.01% |
22,160
+4,825
| +28% | +$21.9K |
|
5048
PLAYSTUDIOS Inc
MYPS
$90.1M
| $96.1K | ﹤0.01% |
51,671
+11,254
| +28% | +$19.3K |
|
|
ESSA
5049
DELISTED
ESSA Bancorp
ESSA
| $96K | ﹤0.01% |
4,922
+1,072
| +28% | +$21K |
|
|
GPMT
5050
Granite Point Mortgage Trust
GPMT
$61.2M
| $96K | ﹤0.01% |
34,395
+6,599
| +24% | +$20.8K |
|
Similar funds
Wells Fargo's Q4 2024 Portfolio in Review
As of Q4 2024, Wells Fargo held 7,328 positions worth $443B, up 0.37% from $442B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Wells Fargo's Q4 2024 filing shows 529 new, 3,410 increased, 2,105 reduced and 370 closed positions. Its largest new stake was Eaton Vance Total Return Bond ETF: 2,595,720 shares worth $129M. The largest sale was UnitedHealth, an estimated $645M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Wells Fargo's largest Q4 2024 buy was Eaton Vance Total Return Bond ETF: 2,595,720 shares worth $129M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $1.37B increase.
- Wells Fargo's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $645M.
- Wells Fargo fully exited Invesco BulletShares 2024 Corporate Bond ETF in Q4 2024, selling an estimated $66M.
- Wells Fargo's ten largest holdings make up 19% of its $443B portfolio in Q4 2024.
- Wells Fargo opened 529 new positions and closed 370 in Q4 2024.
- Wells Fargo's portfolio value rose 0.37% quarter-over-quarter to $443B.
Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.